Pharma Industry News

t.bio chooses Automata as partner for automating a key aspect of its production of iPSC derived human cells

Written by David Miller

Published date:

26/01/2023

Summary:

Automation will support bit.bio’s production of its scalable, consistent human cells for research and drug discovery with greater manufacturing capacity and speed than ever

26th January 2023, London UKAutomata, a leading robotics and automation company powering life sciences labs, today announced it is partnering with

read more

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]